Cargando…
A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry
Ebola virus (EBOV) causes highly lethal disease outbreaks against which no FDA-approved countermeasures are available. Although many host factors exploited by EBOV for cell entry have been identified, including host cell surface phosphatidylserine receptors, endosomal cysteine proteases, and the lys...
Autores principales: | Fels, J. Maximilian, Spence, Jennifer S., Bortz, Robert H., Bornholdt, Zachary A., Chandran, Kartik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747718/ https://www.ncbi.nlm.nih.gov/pubmed/31289183 http://dx.doi.org/10.1128/mBio.01408-19 |
Ejemplares similares
-
A Glycoprotein Mutation That Emerged during the 2013–2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion
por: Fels, J. Maximilian, et al.
Publicado: (2021) -
Real-Time Analysis of Individual Ebola Virus Glycoproteins Reveals Pre-Fusion, Entry-Relevant Conformational Dynamics
por: Durham, Natasha D., et al.
Publicado: (2020) -
Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry
por: Wang, Jizhen, et al.
Publicado: (2011) -
Hyperstabilization of T cell microvilli contacts by chimeric antigen receptors
por: Beppler, Casey, et al.
Publicado: (2022) -
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
por: Torrents de la Peña, Alba, et al.
Publicado: (2017)